8012 J . Org. Chem., Vol. 64, No. 21, 1999
Notes
(2S,3S)-2-Am in o-1-p h en yl-5-h exen -3-ol (10a ). A solution
of 9a (110 mg, 0.38 mmol) in 4 N HCl/dioxane (2/1) solution (12
mL) was stirred under Ar atmosphere for 1 h at room temper-
ature and concentrated in vacuo. The solution was adjusted to
pH ) 9 with NH4OH, and extracted three times with EtOAc.
The organic extracts were dried over Na2SO4, filtered and
concentrated in vacuo giving 62 mg (85%) of pure 10a as a thick
oil. [R]24D +31.2 (c 1.00, MeOH); MS (EI) m/z 191 (M+), 176, 150,
120, 91; 1H NMR (200 MHz) δ 1.55-2.20 (bs, 3H), 2.25-2.55
(m, 3H), 2.85-3.20 (m, 2H), 3.50-3.70 (bs, 1H), 5.05-5.25 (m,
2H), 5.80-6.00 (m, 1H), 7.10-7.35 (m, 5H); 13C NMR (75.46
MHz) δ 37.2, 38.2, 56.2, 73.1, 117.7, 126.4, 128.5, 129.2, 135.1,
139.2.
(4S,5S)-4-Ben zyl-5-(1-pr open yl)-1,3-oxazolidin -2-on e (11a).
To 60 mg (0.32 mmol) of 10a in THF (1.6 mL) were added
carbonyldiimidazole (73 mg, 0.45 mmol) and a catalytic amount
of DMAP (5.0 mg, 0.04 mmol, 12% mol) at room temperature.
After being stirred at the same temperature for 24 h, the reaction
mixture was diluted with saturated aqueous NH4Cl. The aque-
ous phase was extracted with EtOAc, and the organic extracts
were washed with brine, dried over Na2SO4 and concentrated
in vacuo. Purification with preparative silica gel plates (petro-
leum ether:EtOAc ) 2:1) afforded 65 mg (93%) of 11a as a pale
yellow oil. IR: 3480, 1750 cm-1; MS (EI) m/z 217 (M+), 175, 126,
91; 1H NMR (200 MHz) δ 2.35-2.70 (m, 3H), 2.80-3.00 (m, 1H),
3.90-4.05 (m, 1H), 4.60-4.75 (m, 1H), 5.15-5.25 (m, 2H), 5.65
(bs, 1H), 5.70-5.90 (m, 1H), 7.00-7.35 (m, 5H); 13C NMR (75.46
MHz) δ 33.6, 36.2, 56.6, 78.8, 118.6, 127.2, 128.9, 129.1, 132.4,
136.5, 158.3.
0.336 mmol) in CH2Cl2 (64 mL) under the same conditions used
in the reaction of 5. H NMR spectrum of the crude showed the
1
presence of a single diastereoisomer which was purified by
column chromatography on silica gel (petroleum ether:Et2O )
6:1) to give 1.13 g (60%) of pure (4R,5S,6S)-5-[N-(ter t-bu toxy-
ca r b on yl)a m in o]-4-[d im e t h yl(p h e n yl)silyl]-6-m e t h yl-1-
octen -4-ol (8) as a pale yellow oil. [R]24 -7.00 (c 2.15, CHCl3);
D
IR: 3600, 3460, 1700, 1240 cm-1; MS (EI) m/z 391 (M+), 274,
245, 186, 135, 86, 57; 1H NMR (300 MHz) δ 0.381 (s, 3H), 0.406
(s, 3H), 0.55 (t, 3H, J ) 7.0 Hz), 0.75-0.90 (m, 5H), 1.39 (s, 9H),
1.60-1.90 (m, 2H), 2.24 (dd, 1H, J ) 13.9, 8.2 Hz), 2.42 (dd, 1H,
J ) 13.9, 7.2 Hz), 3.66 (dd, 1H, J ) 10.2, 2.1 Hz), 4.68 (d, 1H, J
) 10.2 Hz), 4.90-5.10 (m, 2H), 5.70-5.90 (m, 1H), 7.25-7.40
(m, 3H), 7.55-7.65 (m, 2H); 13C NMR (75.46 MHz) δ -3.5, -3.4,
11.3, 18.2, 23.5, 28.3, 37.9, 42.6, 59.4, 73.6, 78.8, 118.9, 127.7,
129.1, 133.5, 134.6, 137.5, 154.6. Anal. Calcd for C22H37NO3Si:
C, 67.48; H, 9.53; N, 3.58. Found: C, 67.45; H, 9.50; N, 3.56.
In d iu m -Med ia ted Allyla tion of 6. The reaction was per-
formed as described for 5, starting from 6 (349 mg, 1.0 mmol),
allyl bromide (0.20 mL, 2.34 mmol), and In (126 mg, 1.1 mmol)
in 3 mL of THF. Column chromatography on silica gel gave 371
mg of 8 (95%). When the same reaction was carried out in THF/
H2O (2:1) as a solvent, a 53% yield was obtained in 12 h.
(4S,5S,6S)-6-Meth yl-5-[N-(ter t-bu toxyca r bon yl)a m in o]-
1-octen -4-ol (12). This compound was prepared with the same
procedure used for 9a starting from 8 (1.12 g, 2.86 mmol) in
THF (48 mL) and 3.18 mL (3.18 mmol) of a 1.0 M solution of
1
TBAF in THF. H and 13C NMR spectrum of the crude showed
the presence of a single diastereoisomer. Subsequent purification
by column chromatography on silica gel (petroleum ether:Et2O
) 3:1) gave 680 mg (92%) of pure 12 as a white solid. Mp )
(2S,3R)-1-P h en yl-2-[N-(ter t-b u t oxyca r b on yl)a m in o]-5-
h exen -3-ol (9b). The title compound was obtained as previously
described for 9a , starting from 7b (250 mg, 0.59 mmol) in THF
(8 mL) with TBAF (0.65 mL, 0.65 mmol). Column chromatog-
raphy on silica gel (petroleum ether:Et2O ) 4:1) gave 118 mg
117-119 °C; [R]24 +34.2 (c 1.40, MeOH); IR: 3600, 3470, 1760
D
cm-1; MS (EI) m/z 257 (M+), 200, 186, 130, 86, 57; 1H NMR (300
MHz) δ 0.75-0.90 (m, 6H), 0.95-1.20 (m, 2H), 1.40 (s, 9H),
1.41-1.60 (m, 1H), 2.00 (bs, 1H), 2.10-2.38 (m, 2H), 3.10-3.25
(m, 1H), 3.70-3.83 (m, 1H), 4.80 (d, 1H, J ) 9.9 Hz), 5.05-5.20
(m, 2H), 5.70-5.90 (m, 1H); 13C NMR (75.46 MHz) δ 11.3, 15.8,
25.5, 28.3, 36.6, 39.7, 57.9, 69.6, 78.9, 118.4, 134.7, 156.4. Anal.
Calcd for C14H27NO3: C, 65.32; H, 10.58; N, 5.44. Found: C,
65.2; H, 10.55; N, 5.41.
(69%) of 9b as an oil. [R]24 -22.3 (c 1.00, CHCl3); IR: 3600,
D
3470 cm-1; MS (EI) m/z 291 (M+), 200, 100, 57; 1H NMR (200
MHz) δ 1.35 (s, 9H), 2.15-2.55 (m, 3H), 2.75-2.90 (m, 2H), 3.53
(td, 1H, J ) 6.9, 1.9 Hz), 3.70 (bq, 1H, J ) 8.3 Hz), 4.90 (d, 1H,
J ) 8.8 Hz), 5.03-5.10 (m, 2H), 5.60-5.80 (m, 1H), 7.10-7.30
(m, 5H); 13C NMR (75.46 MHz) δ 28.3, 38.8, 39.3, 55.2, 70.1,
79.3, 118.4, 126.3, 128.4, 129.32, 134.4, 138.4, 156.0. Anal. Calcd
for C17H25NO3: C, 70.06; H, 8.65; N, 4.81. Found: C, 70.04; H,
8.63; N, 4.80. MTPA ester of alcohol 9b: prepared as described
for compound 9a , starting from 9b (26 mg, 0.089 mmol), (R)-
(-)-R-methoxy-R-(trifluoromethyl)phenylacetyl chloride (50 mg,
0.19 mmol) and DIMAP (21 mg, 0.17 mmol) in CH2Cl2 (3 mL).
Purification with preparative silica gel plates of the crude (CH2-
Cl2:petroleum ether ) 1:1) afforded 40 mg (94%) of (R)-MPTA
ester of 9b as a pale yellow oil. 1H NMR (300 MHz) δ 1.30 (s,
9H), 2.30 (dd, J ) 14.0, 9.1 Hz, 1H), 2.30-2.60 (m, 2H), 2.90
(dd, 1H, J ) 14.0, 4.9 Hz), 3.60 (s, 3H), 3.85-4.18 (m, 2H), 5.00-
5.20 (m, 2H), 5.22-5.35 (m, 1H), 5.60-5.82 (m, 1H), 6.80-6.90
(m, 2H), 7.10-7.50 (m, 6H), 7.50-7.70 (m, 2H).
(4S,5S,6S)-5-Am in o-6-m eth yl-1-octen -4-ol (13). The title
compound was prepared as for 10a , using 12 (108 mg, 0.42
mmol), in 4 N HCl/dioxane (2/1) solution (15 mL). After the usual
workup, 53 mg (80%) of 13 was obtained as a pale yellow oil.
[R]24 +6.5 (c 1.00, MeOH), MS (EI) m/z 157 (M+), 116, 100, 86;
D
1H NMR (200 MHz) δ 0.75-1.00 (m, 8H), 1.20 (s, 1H), 1.30-1.50
(m, 3H), 1.85-2.50 (m, 3H), 3.45-3.55 (m, 1H), 4.95-5.15 (m, 2H),
5.75-5.95 (m, 1H); 13C NMR (75.46 MHz) δ 11.4, 14.0, 24.7, 29.7,
39.7, 60.8, 78.8, 119.5, 131.5.
(4S,5S)-5-(1-P r op en yl)-4-[2(S)]-m eth ylp r op yl]-1,3-oxa zo-
lid in -2-on e (14). The title compound was synthesized according
to the procedure reported for 11a , starting from 13 (30 mg, 0.19
mmol), CDI (42 mg, 0.26 mmol), and DMAP (3.0 mg, 0.025
mmol). Purification with preparative silica gel plates (petroleum
ether:AcOEt ) 4:1) gave 22 mg (63%) of 14 as a pale yellow oil.
MS (EI) m/z 183 (M+), 142, 126, 57; 1H NMR (200 MHz) δ 0.70-
0.90 (m, 6H), 1.00-1.50 (m, 3H), 2.30-2.40 (m, 2H), 3.30 (t, 1H,
J ) 4.8 Hz), 4.20-4.35 (m, 1H), 5.00-5.20 (m, 2H), 5.60-5.90
(m, 2H); 13C NMR (75.46 MHz) δ 11.1, 14.0, 24.7, 38.9, 39.7,
60.9, 78.8, 119.5, 131.5, 156.8.
(2S,3R)-2-Am in o-1-p h en yl-5-h exen -3-ol (10b). The title
compound was prepared as described for 10a , using 9b (100 mg,
0.34 mmol) in 4 N HCl/dioxane (2/1) solution (15 mL). After the
standard workup, 59 mg (90%) of 10b were obtained as a thick
oil. [R]24D -20.3 (c 1.00, MeOH); MS (EI) m/z 191 (M+), 176, 150,
120, 100, 91, 77; 1H NMR (200 MHz) δ 1.70-2.20 (bs, 3H), 2.40
(d, 2H, J ) 6.2 Hz), 2.56 (dd, 1H, J ) 9.4, 4.2 Hz), 2.80-3.05
(bs, 2H), 3.45 (bs, 1H), 5.05-5.20 (m, 2H), 5.75-5.95 (m, 1H),
7.10-7.35 (m, 5H); 13C NMR (75.46 MHz) δ 39.1, 41.1, 56.0, 72.4,
117.5, 126.4, 128.6, 129.2, 134.8, 138.6.
Eth yl (3R,4S)-4-[N-(ter t-Bu toxyca r bon yl)a m in o]-3-[d im -
eth yl(p h en yl)silyl]-3-h yd r oxy-5-p h en ylp en ta n oa te (15). To
a solution of 5 (1.32 g, 3.45 mmol) and tert-butyl(dimethyl)silyl
1-ethoxyvinyl ether (836 mg, 4.14 mmol) in CH2Cl2 (7.0 mL) was
added dropwise BF3‚Et2O (0.49 mL, 3.85 mmol) at -78 °C under
Ar atmosphere. After being stirred for 48 h at the same
temperature, the reaction mixture was diluted with CH2Cl2, and
the organic layer was washed with aqueous NaHCO3 and water,
dried over Na2SO4, and concentrated in vacuo. 1H NMR spec-
trum of the crude showed the presence of two diastereoisomers
15a ,b in a 95:5 ratio. This ratio was maintained after purifica-
tion by column chromatography on silica gel (petroleum ether:
Et2O ) 5:1) which gave 991 mg (61%) of 15a and 15b. 15a : MS
(EI) m/z 471 (M+), 398, 370, 354, 276, 164, 135, 120, 91; 1H NMR
(200 MHz) δ 0.40 (s, 3H), 0.50 (s, 3H), 1.10-1.30 (m, 12H), 2.50-
2.65 (m, 3H), 2.96 (dd, 1H, J ) 13.7, 3.1 Hz), 3.90-4.10 (m, 3H),
(4S,5R)-4-Ben zyl-5(1-pr open yl)-1,3-oxazolidin -2-on e (11b).
The title compound was prepared as described for 11a , using
10b (54 mg, 0.28 mmol), CDI (66 mg, 0.41 mmol), DMAP (4 mg,
0.03 mmol, 12%), and THF (1.5 mL). Purification with silica gel
plates (petroleum ether:EtOAc ) 2:1) gave 58 mg (95%) of 11b
as a pale yellow oil. IR: 3480, 1750 cm-1; MS (EI) m/z 217 (M+),
1
175, 126, 91; H NMR (300 MHz) δ 2.20-2.40 (m, 2H), 2.80 (d,
2H, J ) 7.4 Hz), 3.70 (q, 1H, J ) 6.0 Hz), 4.32 (q, 1H, J ) 5.1
Hz), 5.05-5.20 (m, 2H), 5.60-5.95 (m + bs, 2H), 7.05-7.35 (m,
5H); 13C NMR (75.46 MHz) δ 38.5, 41.6, 58.1, 80.8, 119.4, 121.9,
127.2, 128.9, 129.0, 131.2, 158.6.
Sc(OTf)3-Ca ta lyzed Allyla tion of 6. The reaction was
performed starting from 6 (1.69 g, 4.8 mmol) in CH2Cl2 (40 mL),
tetraallyltin (0.58 mL, 679 mg, 2.4 mmol), and Sc(OTf)3 (165 mg,
4.45 (bd, 1H, J ) 11.1 Hz), 4.73 (s, 1H), 6.90-7.70 (m, 10H); 13
C